Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use LINAGLIPTIN TABLETS safely and effectively. See full prescribing information for LINAGLIPTIN TABLETS. LINAGLIPTIN tablets, for oral use Initial U.S. Approval: 2011
Medication labelWhy this: Advisory · dailymed-prescription
Linagliptin tablet is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies (14.1)] . Limitations of Use Linagliptin should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings. Linagliptin has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using linagliptin [see Warnings and Precautions (5.1)].
- generic_name
- linagliptin
- product_names
- linagliptin
- ndc
- 48792-7865, 48792-7865-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en